Telaprevir impairs renal function and increases blood ribavirin concentration during telaprevir/pegylated interferon/ribavirin therapy for chronic hepatitis C-Reference-Cited by-同舟云学术

Telaprevir impairs renal function and increases blood ribavirin concentration during telaprevir/pegylated interferon/ribavirin therapy for chronic hepatitis C

Published:2013-08-25 Issue:5 Volume:21 Page:341-347
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Karino Y.¹,Ozeki I.¹,Hige S.¹,Kimura M.¹,Arakawa T.¹,Nakajima T.¹,Kuwata Y.¹,Sato T.¹,Ohmura T.¹,Toyota J.¹

Affiliation:

1. Department of Hepatology Sapporo Kosei General Hospital Sapporo Japan

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvh.12162

Reference26 articles.

1. Course and outcome of hepatitis C

2. Natural history of chronic hepatitis C;Seeff LB;Hepatology,2002

3. Treatment of Chronic Non-A, Non-B Hepatitis with Recombinant Human Alpha Interferon

4. Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of ledipasvir/sofosbuvir for genotype 1b chronic hepatitis C patients with moderate renal impairment;Hepatology International;2018-03

2. Novel Treatment of Hepatitis C Virus Infection for Patients with Renal Impairment;Journal of Clinical and Translational Hepatology;2016-12-26

3. Treatment of Chronic Hepatitis C with the First-Generation Protease Inhibitor Telaprevir: Its Efficacy and Resistance Mutations;Hepatitis C Virus Treatment;2016-11-02

4. Estimated glomerular filtration rate but not solute carrier polymorphisms influences anemia in HIV–hepatitis C virus coinfected patients treated with boceprevir or telaprevir-based therapy;AIDS;2016-08-24

5. Pharmacogenetics of ribavirin-induced anemia in HCV patients;Pharmacogenomics;2016-06